Refine search
Results 1-2 of 2
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog
1984
Chapman, W.L., jr | Hanson, W.L. | Alving, C.R. | Hendricks, L.D.
Leishmania donovani, dogs (exper.), liposome-encapsulated meglumine antimoniate (LEMA) vs. unencapsulated meglumine antimoniate, LEMA was 700 times more efficacious than the encapsulated drug, liposomes can markedly reduce the drug dosage required for equivalent treatment of visceral leishmaniasis
Show more [+] Less [-]Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine
1995
Bree, H van | Ryssen, B. van | Degryse, H. | Ramon, F.
Six scapulohumeral joints (3 normal joints and 3 joints with radiographic evidence of osteochondrosis) underwent conventional magnetic resonance (MR) imaging and MR scapulohumeral arthrography to evaluate delineation of the articular cartilage. The MR arthrography was performed, using 5 ml of 500 micromolar gadopentetate dimeglumine (Gd-DTPA) as a contrast medium. Delineation of normal articular cartilage and cartilage defects was less accurate after intra-articular administration of Gd-DTPA. Therefore, it was concluded that MR arthrography with Gd-DTPA is unrewarding for evaluation of osteochondrosis lesions.
Show more [+] Less [-]